(Q43189081)

15 November 2017

title

Progression and treatment of HER2-positive breast cancer (English)

1 reference

15 November 2017

April Davoli

1

1 reference

15 November 2017

Barbara A Hocevar

series ordinal

2

1 reference

15 November 2017

Thomas L Brown

series ordinal

3

1 reference

15 November 2017

publication date

20 December 2009

1 reference

Cancer Chemotherapy and Pharmacology

15 November 2017

published in

1 reference

15 November 2017

volume

65

1 reference

15 November 2017

issue

4

1 reference

15 November 2017

page(s)

611-623

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-009-1208-1

15 November 2017

exact match

0 references

cites work

HER2 therapy: molecular mechanisms of trastuzumab resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-009-1208-1

Crossref

reference URL

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/0008-5472.CAN-08-1776

Identifiers

DOI

10.1007/S00280-009-1208-1

1 reference

Dimensions Publication ID

15 November 2017

1035013251

0 references

Fatcat ID

release_oaqg4cgmunfcrjajkrhsmsezea

1 reference

https://api.fatcat.wiki/v0/release/oaqg4cgmunfcrjajkrhsmsezea

Fatcat

reference URL

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference